greeksoup/ stock research
Stock research / United States / CTMX / Planned sales

CytomX Therapeutics, Inc. planned insider sales

In the last twelve months insiders at CytomX Therapeutics, Inc. filed 1 Form 144 notice of planned sales, 101,793 shares worth $461,909 at the time of filing, from 1 seller. The latest, filed 6 November 2025: Sean McCarthy (CEO), 101,793 shares worth $461,909, planned for around 6 November 2025 through Merrill Lynch.

FiledSellerRelationshipSharesValuePlanned saleSold, per Form 4BrokerHow acquiredFiling
6 November 2025Sean McCarthyCeo101,793$461,9096 November 2025101,793 shares from 6 November 2025Merrill LynchStock OptionForm 144
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read moreValue is the filer's own aggregate market value. Sold, per Form 4: the same seller's open-market sales on Form 4 from the notice's date to 90 days after, added up, as they appear on the insiders page; a holder who files no Form 4, such as some large holders, never shows one. What is a Form 144?